<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Rees Scientific: 2026-2027 Strategic Growth and Target Plan</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/3.9.1/chart.min.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&display=swap" rel="stylesheet">
    <script src="https://unpkg.com/lucide@latest"></script> <style>
        /* BASE STYLES from index.html */
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        :root {
            --color-primary: #4F46E5; /* Indigo */
            --color-primary-dark: #4338CA;
            --color-primary-light: #6366F1;
            --color-secondary: #10B981; /* Emerald */
            --color-secondary-dark: #059669;
            --color-tertiary: #F59E0B; /* Amber */
            --color-tertiary-dark: #D97706;
            --color-accent: #3B82F6; /* Blue */
            --color-accent-dark: #2563EB;
            --color-text-primary: #0F172A;
            --color-text-secondary: #475569;
            --color-text-muted: #64748B;
            --color-bg-light: #F8FAFC;
            --color-bg-white: #FFFFFF;
            --color-border: #E2E8F0;
            
            /* Styles from target list.html adjusted to index.html theme */
            --target-primary-blue: #0A3762; /* Deep Blue - Used for target headers/borders */
            --target-secondary-cyan: #14B8A6; /* Teal/Cyan accent - Used for target highlights */
            --target-dark-gray: #4B5593;
        }
        
        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
            background-color: var(--color-bg-light);
            color: var(--color-text-secondary);
            line-height: 1.7;
        }
        
        h1, h2, h3, h4, h5, h6 {
            font-weight: 800;
            color: var(--color-text-primary);
            letter-spacing: -0.025em;
        }
        
        .container-main {
            max-width: 1400px;
            margin: 0 auto;
            padding: 0 1.5rem;
        }
        
        .card {
            background: var(--color-bg-white);
            border-radius: 1rem;
            box-shadow: 0 10px 40px rgba(0, 0, 0, 0.1);
            overflow: hidden;
            transition: all 0.3s ease;
        }
        
        .stat-card {
            background: white;
            padding: 2rem;
            border-radius: 1rem;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.08);
            border: 2px solid var(--color-border);
            transition: all 0.3s ease;
        }
        
        .stat-card-highlight {
            background: linear-gradient(135deg, var(--color-primary) 0%, var(--color-primary-dark) 100%);
            color: white;
            border: none;
            transform: scale(1.05);
        }
        
        .pillar-card {
            background: white;
            border-radius: 1rem;
            padding: 2rem;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.08);
            transition: all 0.3s ease;
            border-top: 6px solid;
            height: 100%;
            display: flex;
            flex-direction: column;
        }
        
        .mandate-box {
            background: rgba(0, 0, 0, 0.03);
            border-radius: 0.75rem;
            padding: 1.5rem;
            margin-top: auto;
            border-left: 4px solid;
        }
        
        .chart-wrapper {
            height: 400px;
            max-width: 100%;
        }
        
        .section-header {
            text-align: center;
            margin-bottom: 3rem;
        }
        
        .action-item {
            display: flex;
            align-items: flex-start;
            padding: 1.5rem;
            background: rgba(255, 255, 255, 0.1);
            border-radius: 0.75rem;
            margin-bottom: 1rem;
            transition: all 0.3s ease;
        }
        
        /* CUSTOM STYLES for target list content (blended colors) */
        
        .infographic-card {
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -2px rgba(0, 0, 0, 0.06);
            border-left: 6px solid var(--target-secondary-cyan); /* Teal border */
            transition: transform 0.3s ease-in-out, box-shadow 0.3s ease-in-out;
            padding: 1.5rem;
            border-radius: 0.75rem;
            background: white;
            height: 100%;
        }
        .infographic-card:hover {
            transform: translateY(-4px);
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -4px rgba(0, 0, 0, 0.05);
        }
        
        .target-region-header {
            background-color: var(--target-primary-blue);
            color: white;
            padding: 1rem 1.5rem;
            border-radius: 0.5rem 0.5rem 0 0;
            font-size: 1.25rem;
            font-weight: 700;
        }
        
        .new-logos-grid {
            display: grid;
            grid-template-columns: repeat(1, minmax(0, 1fr));
            gap: 1.5rem;
        }
        @media (min-width: 1024px) { 
            .new-logos-grid {
                grid-template-columns: repeat(2, minmax(0, 1fr));
            }
        }
        @media (min-width: 1280px) { 
            .new-logos-grid {
                grid-template-columns: repeat(3, minmax(0, 1fr));
            }
        }

        /* Styling for list items in target list sections */
        .target-list-item {
            display: flex;
            align-items: center;
            padding: 0.5rem 0;
            border-bottom: 1px solid #F1F5F9;
        }
        .target-list-item:last-child {
            border-bottom: none;
        }
        .target-icon-list {
            color: var(--target-secondary-cyan);
            margin-right: 0.5rem;
            flex-shrink: 0;
        }

        /* Custom styles from index2.html for aesthetic enhancements */
        .card:hover {
            transform: translateY(-2px);
        }
        .tier-1-bg { background-color: #EF4444; } /* Red 500 */
        .tier-2-bg { background-color: #FBBF24; } /* Amber 400 */
        .tier-3-bg { background-color: #3B82F6; } /* Blue 500 */
        .badge-color-aav { background-color: #9333ea; color: white; } /* Violet 600 */
        .badge-color-cell { background-color: #10b981; color: white; } /* Emerald 500 */
        .badge-color-mrna { background-color: #f97316; color: white; } /* Orange 500 */
        .badge-color-adc { background-color: #06b6d4; color: white; } /* Cyan 500 */
        
    </style>
</head>
<body class="bg-slate-50 text-slate-600 antialiased">
    <div class="container-main py-12 md:py-20">
        
        <header class="text-center mb-16">
            <h1 class="text-5xl md:text-6xl font-black text-slate-900 mb-6">
                The Path to $70 Million
            </h1>
            <p class="text-lg md:text-xl text-slate-600 max-w-4xl mx-auto leading-relaxed">
                A Strategic Sales View: Leveraging regulatory tailwinds and high-value capital investment to achieve <strong class="font-bold text-amber-400">+$10M growth</strong> in the compliance-driven market.
            </p>
        </header>

        <section class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-16">
            <div class="stat-card text-center">
                <div class="text-sm font-semibold text-slate-500 uppercase tracking-wider mb-2">2025 Baseline</div>
                <div class="text-6xl font-black text-slate-800 mb-2">$60M</div>
                <div class="text-sm text-slate-500">Current Annual Revenue</div>
            </div>
            
            <div class="stat-card stat-card-highlight text-center">
                <div class="text-sm font-semibold uppercase tracking-wider mb-2 opacity-90">Targeted Increase</div>
                <div class="text-6xl font-black mb-2">+$10M</div>
                <div class="text-sm opacity-90">2026-2027 Strategic Growth</div>
            </div>
            
            <div class="stat-card text-center">
                <div class="text-sm font-semibold text-slate-500 uppercase tracking-wider mb-2">2027 Goal</div>
                <div class="text-6xl font-black text-slate-800 mb-2">$70M</div>
                <div class="text-sm text-slate-500">New Revenue Target</div>
            </div>
        </section>

        <section class="card card-colored bg-gradient-to-br from-indigo-600 to-indigo-800 p-8 md:p-12 mb-16">
            <div class="section-header text-white">
                <h2>Global Market Context</h2>
                <p class="text-white text-xl">
                    Strong industry tailwinds and massive specialized market potential prove the viability of a high-end, services-focused strategy.
                </p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-3 gap-8 text-center text-white">
                <div class="bg-white/10 p-8 rounded-xl backdrop-blur-sm">
                    <div class="text-5xl font-black text-amber-300 mb-2">$7-9B</div>
                    <div class="text-lg font-bold mb-1 text-indigo-50">Global TAM (2025)</div>
                    <div class="text-sm text-indigo-200">Total Addressable Cold Chain Market</div>
                </div>
                
                <div class="bg-white/10 p-8 rounded-xl backdrop-blur-sm">
                    <div class="text-5xl font-black text-amber-300 mb-2">12-14%</div>
                    <div class="text-lg font-bold mb-1 text-indigo-50">Projected CAGR</div>
                    <div class="text-sm text-indigo-200">Market growth through 2030</div>
                </div>
                
                <div class="bg-white/10 p-8 rounded-xl backdrop-blur-sm">
                    <div class="text-5xl font-black text-emerald-400 mb-2">$1.4-2B</div>
                    <div class="text-lg font-bold mb-1 text-indigo-50">Services TAM</div>
                    <div class="text-sm text-indigo-200">Validation, Mapping, Calibration</div>
                </div>
            </div>
        </section>

        <section class="card p-8 md:p-12 mb-16">
            <div class="section-header">
                <h2>Market Segmentation: High-End Dominance</h2>
                <p>
                    Our focus on the compliance-driven market captures the highest value. The high-end segment represents the majority of industry revenue despite lower unit volume.
                </p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8 max-w-4xl mx-auto">
                <div class="flex items-center p-8 bg-gradient-to-br from-indigo-50 to-indigo-100 rounded-xl border-l-4 border-indigo-500">
                    <div class="text-6xl font-black text-indigo-600 min-w-[120px]">80%</div>
                    <div class="ml-6">
                        <div class="text-xl font-bold text-slate-800 mb-1">High-End Market Value</div>
                        <div class="text-slate-600">Revenue concentrated at <strong class="font-semibold text-slate-800">$1,000‚Äì$1,500+</strong> per monitoring point</div>
                    </div>
                </div>
                
                <div class="flex items-center p-8 bg-gradient-to-br from-emerald-50 to-emerald-100 rounded-xl border-l-4 border-emerald-500">
                    <div class="text-6xl font-black text-emerald-600 min-w-[120px]">20%</div>
                    <div class="ml-6">
                        <div class="text-xl font-bold text-slate-800 mb-1">Low-End Market Value</div>
                        <div class="text-slate-600">Commodity sales at <strong class="font-semibold text-slate-800">$100</strong> per point ‚Äî we avoid this segment</div>
                    </div>
                </div>
            </div>
        </section>

        <section class="card p-8 md:p-12 mb-16">
            <div class="section-header">
                <h2>Regional Allocation: The $10M Growth Plan</h2>
                <p>
                    Growth strategically funneled into high-potential regions with the strongest mix of regulatory and CGT investment.
                </p>
            </div>
            <div class="chart-wrapper">
                <canvas id="growthChart"></canvas>
            </div>
        </section>

        <section class="card p-8 md:p-12 mb-16">
            <div class="section-header">
                <h2>Top 5 Capital Projects: Biggest Growth Potential</h2>
                <p>
                    Prioritize engagement with these confirmed multi-billion dollar capital investments offering massive scope in cleanroom validation and high-end monitoring services.
                </p>
            </div>
            <div class="chart-wrapper h-[500px]">
                <canvas id="megaProjectChart"></canvas>
            </div>
        </section>

        <section class="card card-colored bg-gradient-to-br from-slate-800 to-slate-900 p-8 md:p-12 mb-16">
            <div class="section-header text-white">
                <h2 class="text-white">Strategic Focus: Three Critical Growth Pillars</h2>
                <p class="text-slate-300">
                    Target compliance-driven capital and regulatory mandates. Lock in long-term contracts by leading with high-value service expertise.
                </p>
            </div>
            
            <div class="grid grid-cols-1 lg:grid-cols-3 gap-8">
                <div class="pillar-card" style="border-top-color: var(--color-secondary);">
                    <div class="flex items-center mb-6">
                        <span class="emoji-icon">üî¨</span>
                        <h3 class="text-xl" style="color: var(--color-secondary);">CGT Manufacturing</h3>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Opportunity:</div>
                        <p class="text-slate-600">Massive capital investments in new cleanrooms and labs (25-35% CAGR). Need monitoring for GMP compliance from Day 1.</p>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Value Proposition:</div>
                        <p class="text-slate-600">Secure Centron system sale by leading with high-margin <strong class="font-semibold text-slate-900">IQ/OQ/PQ Validation</strong> services.</p>
                    </div>
                    <div class="mandate-box" style="border-color: var(--color-secondary); background: rgba(16, 185, 129, 0.08);">
                        <div class="font-extrabold text-lg mb-1" style="color: var(--color-secondary);">SALES MANDATE:</div>
                        <div class="font-bold text-slate-800 text-lg">Secure Centron via Validation services</div>
                    </div>
                </div>

                <div class="pillar-card" style="border-top-color: var(--color-accent);">
                    <div class="flex items-center mb-6">
                        <span class="emoji-icon">üá™üá∫</span>
                        <h3 class="text-xl" style="color: var(--color-accent);">Annex 11 Modernization</h3>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Opportunity:</div>
                        <p class="text-slate-600">New EU regulation forces non-compliant firms to upgrade immediately. Large, forced replacement cycle across Europe.</p>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Value Proposition:</div>
                        <p class="text-slate-600">The <strong class="font-semibold text-slate-900">Cloud EMS Platform</strong> is the compliant, scalable replacement for obsolete legacy systems.</p>
                    </div>
                    <div class="mandate-box" style="border-color: var(--color-accent); background: rgba(59, 130, 246, 0.08);">
                        <div class="font-extrabold text-lg mb-1" style="color: var(--color-accent);">SALES MANDATE:</div>
                        <div class="font-bold text-slate-800 text-lg">Target Compliance Officers; Displace legacy with Cloud</div>
                    </div>
                </div>

                <div class="pillar-card" style="border-top-color: var(--color-tertiary);">
                    <div class="flex items-center mb-6">
                        <span class="emoji-icon">üè•</span>
                        <h3 class="text-xl" style="color: var(--color-tertiary);">Specialized Hospital/Lab</h3>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Opportunity:</div>
                        <p class="text-slate-600">Stricter USP/AABB compliance rules create mandatory, high-frequency service needs in Hospital Pharmacies and Blood Storage.</p>
                    </div>
                    <div class="mb-6">
                        <div class="font-semibold text-slate-800 mb-2">Value Proposition:</div>
                        <p class="text-slate-600">Automated reporting and specialized service teams reduce audit risk and ensure quarterly compliance.</p>
                    </div>
                    <div class="mandate-box" style="border-color: var(--color-tertiary); background: rgba(245, 158, 11, 0.08);">
                        <div class="font-extrabold text-lg mb-1" style="color: var(--color-tertiary);">SALES MANDATE:</div>
                        <div class="font-bold text-slate-800 text-lg">Maximize multi-year recurring service revenue</div>
                    </div>
                </div>
            </div>
        </section>

        <section class="card p-8 md:p-12 mb-16">
            <div class="section-header">
                <h2>Product-to-Opportunity Mapping</h2>
                <p>
                    Our products and services are perfectly aligned to capture specific needs within each high-growth niche.
                </p>
            </div>
            
            <div class="grid grid-cols-1 lg:grid-cols-3 gap-8">
                <div class="border-2 border-emerald-500 rounded-xl p-8 bg-gradient-to-br from-emerald-50 to-emerald-100">
                    <h3 class="text-lg font-extrabold text-emerald-600 mb-6">1. CGT Manufacturing</h3>
                    <ul class="list-none space-y-3">
                        <li><span class="text-emerald-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Validation Services:</strong><span class="text-slate-600"> IQ/OQ/PQ Packages (Largest revenue driver)</span></li>
                        <li><span class="text-emerald-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Centron System:</strong><span class="text-slate-600"> High-density sensor deployment</span></li>
                        <li><span class="text-emerald-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">On-site Support:</strong><span class="text-slate-600"> Dedicated cleanroom/lab staff</span></li>
                    </ul>
                </div>

                <div class="border-2 border-blue-500 rounded-xl p-8 bg-gradient-to-br from-blue-50 to-blue-100">
                    <h3 class="text-lg font-extrabold text-blue-600 mb-6">2. Annex 11 Modernization</h3>
                    <ul class="list-none space-y-3">
                        <li><span class="text-blue-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Cloud EMS Platform:</strong><span class="text-slate-600"> Direct legacy replacement</span></li>
                        <li><span class="text-blue-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Part 11 Features:</strong><span class="text-slate-600"> Full audit trail & security</span></li>
                        <li><span class="text-blue-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Global Service:</strong><span class="text-slate-600"> EU-based support contracts</span></li>
                    </ul>
                </div>

                <div class="border-2 border-amber-500 rounded-xl p-8 bg-gradient-to-br from-amber-50 to-amber-100">
                    <h3 class="text-lg font-extrabold text-amber-600 mb-6">3. Specialized Hospital/Lab</h3>
                    <ul class="list-none space-y-3">
                        <li><span class="text-amber-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Recurring Contracts:</strong><span class="text-slate-600"> Guaranteed annual revenue</span></li>
                        <li><span class="text-amber-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Automated Reporting:</strong><span class="text-slate-600"> USP/AABB compliant logs</span></li>
                        <li><span class="text-amber-600 font-bold mr-2">‚úì</span><strong class="text-slate-900">Centron Deployment:</strong><span class="text-slate-600"> Cost-effective remote monitoring</span></li>
                    </ul>
                </div>
            </div>
        </section>

        <section class="grid grid-cols-1 lg:grid-cols-2 gap-8 mb-16">
            <div class="card p-8 md:p-12">
                <h2 class="text-center mb-4">Competitive Positioning</h2>
                <p class="text-center text-slate-600 mb-8">
                    We differentiate through superior service and regulatory expertise, competing with peers like <strong class="font-semibold text-slate-800">Vaisala</strong> and <strong class="font-semibold text-slate-800">XiltriX</strong>.
                </p>
                <div class="chart-wrapper h-[450px]">
                    <canvas id="competitiveChart"></canvas>
                </div>
            </div>

            <div class="card card-colored bg-gradient-to-br from-indigo-600 to-indigo-800 p-8 md:p-12">
                <h2 class="text-center text-white mb-4">Actionable Next Steps</h2>
                <p class="text-center text-white/95 mb-8 text-lg">
                    To execute the $70M goal, sales leadership recommends:
                </p>
                
                <div class="action-item">
                    <span class="text-5xl mr-6 shrink-0">üë•</span>
                    <div>
                        <div class="font-bold text-xl mb-1 text-white">Immediate AE Hire</div>
                        <div class="text-white/95">Focus on <strong class="font-semibold text-amber-300">Boston/MA</strong> and <strong class="font-semibold text-amber-300">California</strong> to capture high-value project pipeline.</div>
                    </div>
                </div>
                
                <div class="action-item">
                    <span class="text-5xl mr-6 shrink-0">üõ†Ô∏è</span>
                    <div>
                        <div class="font-bold text-xl mb-1 text-white">Bundle Service Contracts</div>
                        <div class="text-white/95">Ensure all capital equipment bids include IQ/OQ/PQ and multi-year calibration contracts.</div>
                    </div>
                </div>
                
                <div class="action-item">
                    <span class="text-5xl mr-6 shrink-0">üíª</span>
                    <div>
                        <div class="font-bold text-xl mb-1 text-white">Regulatory Push</div>
                        <div class="text-white/95">Launch targeted campaigns in Europe and hospital systems promoting compliance migration paths.</div>
                    </div>
                </div>
            </div>
        </section>
        
        <hr class="my-16 border-t-4 border-indigo-400">
        
        <header class="max-w-7xl mx-auto mb-10 p-6 bg-white rounded-xl shadow-lg">
            <div class="flex flex-col md:flex-row justify-between items-center">
                <div class="text-center md:text-left">
                    <h2 class="text-3xl sm:text-4xl font-extrabold text-slate-900 leading-tight">
                        Detailed HLS Target Plan
                    </h2>
                    <p class="text-lg text-gray-600 mt-1">
                        Prioritizing High-Value, Quick-Win Lab Targets for 2026
                    </p>
                </div>
            </div>
            <hr class="mt-4 border-t-2 border-target-secondary-cyan">
        </header>

        <section class="max-w-7xl mx-auto mb-16">
            <h2 class="text-2xl font-bold text-slate-900 mb-6 border-b-2 border-target-secondary-cyan pb-2">
                Top 6 Near-Term Opportunities (Lab, Pharmacy, & CGT Focus)
            </h2>
            <p class="text-gray-600 mb-4 text-base font-semibold italic">
                Focus shifted to mid-size, high-spec lab builds (sub-\$1B) that offer faster sales cycles and immediate fit for high-end Rees monitoring and service needs.
            </p>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">

                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="cross"></span>
                        1. CCHMC Liberty Campus
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Butler County, OH | <span class="text-target-secondary-cyan">~$365M</span> Expansion</p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: Major Lab/Pharmacy/Sterile Processing build-out.</li>
                        <li>Element: USP 797/800 compliance opportunity.</li>
                        <li>Value: Immediate hospital fit for lab and pharmacy monitoring (quick win).</li>
                    </ul>
                </div>

                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="radio-tower"></span>
                        2. Novartis Radioligand Mfg
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Carlsbad, CA | <span class="text-target-secondary-cyan">Specialized Niche</span></p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: Highly specialized cGMP labs and manufacturing.</li>
                        <li>Element: Extreme precision validation and high-end monitoring needed.</li>
                        <li>Value: High-value niche win that reinforces Rees's high-end focus.</li>
                    </ul>
                </div>
                
                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="vial"></span>
                        3. Dana‚ÄëFarber Mfg Labs
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Boston, MA | <span class="text-target-secondary-cyan">Targeted Lab Scope</span></p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: Dedicated manufacturing labs / clean-rooms component.</li>
                        <li>Element: CGT clean-room monitoring and validation.</li>
                        <li>Value: Premium client in key region; targeting the *lab* part for rapid entry.</li>
                    </ul>
                </div>

                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="building"></span>
                        4. The Pearl Innovation District
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Charlotte, NC | <span class="text-target-secondary-cyan">High-Density Labs</span></p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: New life-sciences research buildings with multiple tenants.</li>
                        <li>Element: High volume of smaller individual lab environments.</li>
                        <li>Value: Excellent way to land multiple new logos in a strong, growing region (NC).</li>
                    </ul>
                </div>

                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="graduation-cap"></span>
                        5. U of Oklahoma Life-Sci
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Norman, OK | <span class="text-target-secondary-cyan">Multiple New Builds</span></p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: Research labs and university infrastructure expansion.</li>
                        <li>Element: Academic lab automation & monitoring (low competitive resistance).</li>
                        <li>Value: Academic wins are often quick, creating reference sites and driving service brand.</li>
                    </ul>
                </div>
                
                <div class="infographic-card bg-white">
                    <h3 class="text-lg font-bold text-target-primary-blue flex items-center mb-2">
                        <span class="target-icon-list" data-lucide="microscope"></span>
                        6. NIH SRLM Laboratory Wing
                    </h3>
                    <p class="text-sm text-gray-700 font-semibold">Bethesda, MD (Federal) | <span class="text-target-secondary-cyan">Lab Focus</span></p>
                    <ul class="list-disc list-inside text-sm text-gray-600 mt-2 space-y-1">
                        <li>Focus: New Laboratory Medicine & Research Labs in major hospital context.</li>
                        <li>Element: High-spec research labs in a compliance-heavy federal setting.</li>
                        <li>Value: Direct, high-end lab opportunity within the priority ARC-NIH region.</li>
                    </ul>
                </div>
                
            </div>
        </section>
        
        
        <section class="max-w-7xl mx-auto mb-12">
            <h2 class="text-2xl font-bold text-slate-900 mb-6 border-b-2 border-target-primary-blue pb-2">
                Top New Logo Targets by Region (Balanced HLS Focus)
            </h2>

            <div class="new-logos-grid">

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">1Ô∏è‚É£ Northeast Region</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-1 text-sm text-target-dark-gray">
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>NYU Langone Health ‚Äì NY (Academic/CGT Focus)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Moderna ‚Äì Laval mRNA Vaccine Facility ‚Äì QC, Canada</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Bristol-Myers Squibb ‚Äì Dev. & Mfg sites (NJ/MA)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Hackensack Meridian Health ‚Äì NJ</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>NYC Health + Hospitals ‚Äì NY (Pharmacy/Compliance)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>UPMC ‚Äì PA (Regional Hospital Network)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>CRISPR Therapeutics ‚Äì Boston/MA CGT Labs</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Yale New Haven Health ‚Äì CT</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Regeneron Pharmaceuticals ‚Äì NY R&D Campus</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Northwell Health ‚Äì NY</li>
                        </ul>
                    </div>
                </div>

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">2Ô∏è‚É£ Southern Region</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-1 text-sm text-target-dark-gray">
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Eli Lilly and Company ‚Äì Houston biomanufacturing campus ‚Äì TX</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Genentech ‚Äì Holly Springs manufacturing site ‚Äì NC</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Amgen ‚Äì North Carolina biologics plant ‚Äì NC</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Texas Medical Center (system-level, non-client entities) ‚Äì TX</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Houston Methodist ‚Äì TX (Major Research Center)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Texas Children‚Äôs Hospital ‚Äì TX (Pediatric Research)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Kite Pharma (Gilead) ‚Äì Frederick, MD (CGT Mfg)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Atrium Health ‚Äì NC/GA</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Baptist Health South Florida ‚Äì FL</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Catalent ‚Äì NC/FL CDMO Sites (cGMP Focus)</li>
                        </ul>
                    </div>
                </div>

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">3Ô∏è‚É£ SW Central Region</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-1 text-sm text-target-dark-gray">
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Amgen ‚Äì Ohio biomanufacturing facility ‚Äì OH</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Ohio State University Wexner Medical Center ‚Äì OH</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Nationwide Children‚Äôs Hospital ‚Äì OH (CGT Trials)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>University of Michigan Health ‚Äì MI</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>AbbVie ‚Äì North Chicago R&D Campus ‚Äì IL</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Corewell Health ‚Äì MI</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>SSM Health ‚Äì MO</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Bayer U.S. ‚Äì Animal Health R&D/Mfg (KS)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Banner Health ‚Äì AZ</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>University of Colorado Anschutz Medical Campus ‚Äì CO</li>
                        </ul>
                    </div>
                </div>

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">4Ô∏è‚É£ West Region</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-1 text-sm text-target-dark-gray">
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Gilead Sciences ‚Äì Foster City campus expansion ‚Äì CA</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Amgen ‚Äì California manufacturing/R&D sites ‚Äì CA</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Seattle Genetics (Seagen/Pfizer) ‚Äì WA R&D/Mfg</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>UW Medicine ‚Äì WA (Academic Research)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Cedars-Sinai Medical Center ‚Äì CA</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Illumina ‚Äì San Diego R&D/Genomics (Automation focus)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>San Diego State University ‚Äì new LS/STEM builds ‚Äì CA</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Seattle Children‚Äôs Hospital ‚Äì WA (Biorepositories)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Bristol-Myers Squibb ‚Äì Redwood City/CA CGT Sites</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Fred Hutchinson Cancer Center ‚Äì WA</li>
                        </ul>
                    </div>
                </div>

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">5Ô∏è‚É£ Europe Region</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-1 text-sm text-target-dark-gray">
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Novo Nordisk ‚Äì Athlone / GLP-1 related investments ‚Äì IE</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Cell and Gene Therapy Catapult ‚Äì manufacturing centres (e.g., Stevenage) ‚Äì UK</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Ardena ‚Äì expanded bioanalytical/CDMO footprint ‚Äì NL/SE</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Charit√© ‚Äì Universit√§tsmedizin Berlin ‚Äì DE</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>AstraZeneca ‚Äì Cambridge R&D campus ‚Äì UK</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>Lonza ‚Äì Drug Product/Biologics Sites (CH/IE)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Boston Scientific ‚Äì Galway operations ‚Äì IE (Med Device/Cleanroom)</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>AGC Pharma Chemicals Europe ‚Äì Barcelona HPAPI expansion ‚Äì ES</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="chevron-right"></span>Berlin Institute of Health ‚Äì DE</li>
                            <li class="target-list-item"><span class="target-icon-list" data-lucide="flask-conical"></span>GE Healthcare ‚Äì Cork contrast media site ‚Äì IE</li>
                        </ul>
                    </div>
                </div>

                <div class="rounded-xl shadow-lg overflow-hidden border border-gray-200">
                    <div class="target-region-header">6Ô∏è‚É£ Federal / National Targets</div>
                    <div class="p-4 bg-white">
                        <ul class="space-y-3 text-sm text-target-dark-gray">
                            <li>
                                <div class="text-target-primary-blue font-bold mb-1">NIH Modernization (Bethesda, MD Focus)</div>
                                <div class="flex items-start">
                                    <span class="target-icon-list mt-1" data-lucide="check-circle"></span>
                                    <div class="ml-1">\$1.7B SRLM Wing (547k sq-ft) & 341k sq-ft of cGMP/BSL-3 lab renovations (Bldg 10 & 29B) through 2029.</div>
                                </div>
                            </li>
                            <li>
                                <div class="text-target-primary-blue font-bold mt-3 mb-1">ARC (American Red Cross) National Upgrades</div>
                                <div class="flex items-start">
                                    <span class="target-icon-list mt-1" data-lucide="check-circle"></span>
                                    <div class="ml-1">New regional HQs (TX, ME, WA) consolidating blood donation/disaster ops with major cold-chain/storage upgrades.</div>
                                </div>
                            </li>
                            <li>
                                <div class="text-target-primary-blue font-bold mt-3 mb-1">Strategic Value</div>
                                <div class="flex items-start">
                                    <span class="target-icon-list mt-1" data-lucide="check-circle"></span>
                                    <div class="ml-1">Long-term federal contracts driven by public health/research modernization and critical environment control needs.</div>
                                </div>
                                <div class="flex items-start">
                                    <span class="target-icon-list mt-1" data-lucide="check-circle"></span>
                                    <div class="ml-1">Driven by AABB quarterly alarm testing and USP enforcement.</div>
                                </div>
                            </li>
                        </ul>
                    </div>
                </div>

            </div>
        </section>


        <footer class="max-w-7xl mx-auto mt-10 p-6 bg-gradient-to-br from-indigo-700 to-indigo-900 rounded-xl shadow-lg text-white">
            <h3 class="text-xl font-bold border-b pb-2 border-amber-400">Strategic Summary (Target List Focus)</h3>
            <p class="mt-3 text-base opacity-95">
                This document outlines a clear two-part strategy for growth, prioritizing quick, profitable wins in our sweet spot:
            </p>
            <ul class="list-disc list-inside mt-2 space-y-1 text-sm opacity-90 pl-4">
                <li>Near-Term Wins: Focus sales on high-spec, compliance-driven lab and pharmacy expansions (e.g., CCHMC, Novartis, Innovation Districts) where Rees can deploy monitoring and service faster.</li>
                <li>Federal Win: Prioritize the Federal/National Targets (ARC - NIH) to capture the long-cycle federal budget for hospital modernization and blood center regulatory compliance (AABB, cGMP).</li>
                <li>Broad Coverage: Drive new logo acquisition using the highly targeted Regional Lists, balanced between large compliance-driven Hospital Networks and high-value Biotech/Pharma manufacturing and R&D centers.</li>
            </ul>
            <p class="mt-4 text-xs text-gray-300">
                *Note: While massive capital projects like Merck and Lilly are still observed, they are no longer primary 2026 revenue drivers; rather, they serve as long-term reference targets.*
            </p>
        </footer>

        <hr class="my-16 border-t-4 border-indigo-400">

        <!-- START: Content from index2.html -->
        <div class="max-w-7xl mx-auto">
            <header class="mb-8 border-b pb-4">
                <h1 class="text-4xl font-extrabold text-gray-900 mb-2">Europe Prospecting Initiative</h1>
                <p class="text-gray-500">Prioritized target list built for Nov 18, 2025. Total prospects: 150.</p>
            </header>
    
            <!-- Summary Cards -->
            <div class="grid grid-cols-1 md:grid-cols-4 gap-6 mb-12">
                <div class="card p-5 bg-white rounded-xl border border-gray-200">
                    <div class="flex items-center justify-between">
                        <p class="text-sm font-medium text-gray-500">Tier 1 Targets</p>
                        <i data-lucide="zap" class="w-5 h-5 text-red-500"></i>
                    </div>
                    <p class="text-3xl font-bold text-gray-900 mt-1">42</p>
                    <span class="text-xs text-red-500 font-semibold mt-1 block">MUST CALL THIS QUARTER</span>
                </div>
                <div class="card p-5 bg-white rounded-xl border border-gray-200">
                    <div class="flex items-center justify-between">
                        <p class="text-sm font-medium text-gray-500">Total Prospect List</p>
                        <i data-lucide="layers-3" class="w-5 h-5 text-blue-500"></i>
                    </div>
                    <p class="text-3xl font-bold text-gray-900 mt-1">150</p>
                    <span class="text-xs text-gray-400 font-semibold mt-1 block">Tier 1 (42) + Tier 2 (58) + Tier 3 (50)</span>
                </div>
                <div class="card p-5 bg-white rounded-xl border border-gray-200">
                    <div class="flex items-center justify-between">
                        <p class="text-sm font-medium text-gray-500">Key Focus Modality</p>
                        <i data-lucide="dna" class="w-5 h-5 text-purple-600"></i>
                    </div>
                    <p class="text-3xl font-bold text-gray-900 mt-1">Cell & Gene Therapy</p>
                    <span class="text-xs text-purple-600 font-semibold mt-1 block">AAV, CAR-T, iPSC, mRNA, ADC</span>
                </div>
                <div class="card p-5 bg-white rounded-xl border border-gray-200">
                    <div class="flex items-center justify-between">
                        <p class="text-sm font-medium text-gray-500">Top Country Cluster</p>
                        <i data-lucide="flag" class="w-5 h-5 text-emerald-500"></i>
                    </div>
                    <p class="text-3xl font-bold text-gray-900 mt-1">United Kingdom</p>
                    <span class="text-xs text-emerald-500 font-semibold mt-1 block">London, Cambridge, Oxford, Stevenage</span>
                </div>
            </div>
    
            <!-- Prioritization Chart -->
            <div class="bg-white p-6 rounded-xl border border-gray-200 mb-12">
                <h2 class="text-xl font-bold text-gray-900 mb-4 flex items-center">
                    <i data-lucide="scatter-chart" class="w-5 h-5 text-indigo-600 mr-2"></i> Tier 1 Landscape: Funding vs. Scale
                </h2>
                <div class="h-96">
                    <canvas id="prioritizationChart"></canvas>
                </div>
                <p class="text-sm text-gray-500 mt-4">
                    <strong>Y-Axis: Total Raised</strong> (Proxy for Investment/Lab Buildout). <strong>X-Axis: Employee Count</strong> (Proxy for Current Scale). Larger bubbles indicate public companies or massive organizations (Lonza, Novo Nordisk).
                </p>
            </div>
    
            <!-- Tier 1 Detailed Table -->
            <div class="bg-white p-6 rounded-xl border border-gray-200">
                <h2 class="text-xl font-bold text-gray-900 mb-4 flex items-center">
                    <i data-lucide="list-checks" class="w-5 h-5 text-red-500 mr-2"></i> Tier 1 Targets (42 Companies)
                </h2>
    
                <div class="overflow-x-auto">
                    <table class="min-w-full divide-y divide-gray-200">
                        <thead class="bg-gray-50">
                            <tr>
                                <th scope="col" class="px-3 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Rank</th>
                                <th scope="col" class="px-6 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Company</th>
                                <th scope="col" class="px-6 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Country / City</th>
                                <th scope="col" class="px-6 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Focus / Modality</th>
                                <th scope="col" class="px-6 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Total Raised</th>
                                <th scope="col" class="px-6 py-3 text-left text-xs font-semibold text-gray-500 uppercase tracking-wider">Employees</th>
                            </tr>
                        </thead>
                        <tbody class="bg-white divide-y divide-gray-200" id="tier1TableBody">
                            <!-- Data will be inserted here -->
                        </tbody>
                    </table>
                </div>
                <p class="text-sm text-gray-500 mt-4">
                    *The full 42 Tier 1 companies are included in the source data. Showing a representative top 20 here for dashboard brevity
                </p>
            </div>
        </div>
        <!-- END: Content from index2.html -->
        
    </div>

    <script>
        // CHART JAVASCRIPT from index.html
        const colors = {
            primary: '#4F46E5',
            secondary: '#10B981',
            tertiary: '#F59E0B',
            accent: '#3B82F6',
            slate: '#64748B',
            lightSlate: '#94A3B8'
        };
        
        const chartDefaults = {
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                legend: {
                    labels: {
                        color: '#0F172A',
                        font: { family: 'Inter', size: 13, weight: '600' },
                        padding: 15
                    }
                },
                tooltip: {
                    backgroundColor: 'rgba(15, 23, 42, 0.95)',
                    padding: 12,
                    titleFont: { family: 'Inter', size: 14, weight: '700' },
                    bodyFont: { family: 'Inter', size: 13 },
                    borderColor: '#E2E8F0',
                    borderWidth: 1
                }
            }
        };

        function initMainCharts() {
            // Regional Growth Chart
            if(document.getElementById('growthChart')) {
                new Chart(document.getElementById('growthChart'), {
                    type: 'bar',
                    data: {
                        labels: ['Northeast', 'West', 'Europe', 'ARC‚ÄìNIH', 'Southern/TX', 'Southeast'],
                        datasets: [{
                            label: 'Target Growth ($M)',
                            data: [3.0, 2.5, 2.0, 1.0, 1.0, 0.5],
                            backgroundColor: colors.secondary,
                            borderRadius: 8,
                            barThickness: 50
                        }]
                    },
                    options: {
                        ...chartDefaults,
                        indexAxis: 'y',
                        scales: {
                            x: {
                                beginAtZero: true,
                                grid: { display: true, color: '#F1F5F9' },
                                title: { 
                                    display: true, 
                                    text: 'Allocated Growth (Millions $)', 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 14, weight: '700' },
                                    padding: 10
                                },
                                ticks: { 
                                    color: '#475569',
                                    font: { family: 'Inter', size: 12, weight: '600' },
                                    callback: (value) => '+' + value + 'M'
                                }
                            },
                            y: { 
                                grid: { display: false },
                                ticks: { 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 13, weight: '600' },
                                    padding: 8
                                }
                            }
                        },
                        plugins: { 
                            ...chartDefaults.plugins, 
                            legend: { display: false }
                        }
                    }
                });
            }

            // Top 5 Projects Chart
            if(document.getElementById('megaProjectChart')) {
                new Chart(document.getElementById('megaProjectChart'), {
                    type: 'bar',
                    data: {
                        labels: [
                            ['Merck CoE', '(Elkton, VA)'],
                            ['J&J/FUJIFILM', '(Holly Springs, NC)'],
                            ['Dana-Farber', '(Boston, MA)'],
                            ['GSK Flex Factory', '(Upper-Merion, PA)'],
                            ['Amgen R&D', '(Thousand Oaks, CA)']
                        ],
                        datasets: [{
                            label: 'Capital Investment',
                            data: [3.0, 2.0, 1.675, 1.2, 0.6],
                            backgroundColor: [colors.accent, colors.accent, colors.primary, colors.accent, colors.primary],
                            borderRadius: 8,
                            barThickness: 60
                        }]
                    },
                    options: {
                        ...chartDefaults,
                        scales: {
                            y: {
                                beginAtZero: true,
                                grid: { display: true, color: '#F1F5F9' },
                                title: { 
                                    display: true, 
                                    text: 'Capital Spend (Billions $)', 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 14, weight: '700' },
                                    padding: 10
                                },
                                ticks: { 
                                    color: '#475569',
                                    font: { family: 'Inter', size: 12, weight: '600' },
                                    callback: (value) => '+' + value + 'B'
                                }
                            },
                            x: { 
                                grid: { display: false },
                                ticks: { 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 12, weight: '600' },
                                    padding: 8
                                }
                            }
                        },
                        plugins: { 
                            ...chartDefaults.plugins, 
                            legend: { display: false }
                        }
                    }
                });
            }

            // Competitive Positioning Bubble Chart
            if(document.getElementById('competitiveChart')) {
                new Chart(document.getElementById('competitiveChart'), {
                    type: 'bubble',
                    data: {
                        datasets: [
                            {
                                label: 'High-End / Compliance',
                                data: [
                                    { x: 9, y: 10, r: 18, label: 'Rees Scientific' },
                                    { x: 8, y: 9, r: 12, label: 'Vaisala' },
                                    { x: 7, y: 8, r: 11, label: 'XiltriX' },
                                    { x: 6, y: 7, r: 9, label: 'ELPRO' }
                                ],
                                backgroundColor: colors.primary + 'dd',
                                borderColor: colors.primary,
                                borderWidth: 2
                            },
                            {
                                label: 'Mid-Tier / R&D',
                                data: [
                                    { x: 5, y: 5, r: 8, label: 'Elemental Machines' },
                                    { x: 4, y: 4, r: 7, label: 'Dickson' }
                                ],
                                backgroundColor: colors.accent + 'dd',
                                borderColor: colors.accent,
                                borderWidth: 2
                            },
                            {
                                label: 'Low-End / Commodity',
                                data: [
                                    { x: 3, y: 3, r: 7, label: 'TempGenius' },
                                    { x: 2, y: 2, r: 6, label: 'Sensaphone' }
                                ],
                                backgroundColor: colors.lightSlate + 'dd',
                                borderColor: colors.slate,
                                borderWidth: 2
                            }
                        ]
                    },
                    options: {
                        ...chartDefaults,
                        plugins: {
                            ...chartDefaults.plugins,
                            legend: { 
                                position: 'bottom',
                                labels: {
                                    ...chartDefaults.plugins.legend.labels,
                                    padding: 20
                                }
                            },
                            tooltip: {
                                ...chartDefaults.plugins.tooltip,
                                callbacks: {
                                    label: (context) => {
                                        const item = context.dataset.data[context.dataIndex];
                                        return ` ${item.label} (Complexity: ${item.x}, Compliance: ${item.y})`;
                                    },
                                    title: () => ''
                                }
                            }
                        },
                        scales: {
                            x: {
                                min: 0,
                                max: 10,
                                grid: { color: '#F1F5F9' },
                                title: { 
                                    display: true, 
                                    text: 'System Complexity / Price ‚Üí', 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 13, weight: '700' },
                                    padding: 10
                                },
                                ticks: {
                                    color: '#475569',
                                    font: { family: 'Inter', size: 11, weight: '600' }
                                }
                            },
                            y: {
                                min: 0,
                                max: 10,
                                grid: { color: '#F1F5F9' },
                                title: { 
                                    display: true, 
                                    text: 'Regulatory Compliance Focus ‚Üí', 
                                    color: '#0F172A', 
                                    font: { family: 'Inter', size: 13, weight: '700' },
                                    padding: 10
                                },
                                ticks: {
                                    color: '#475569',
                                    font: { family: 'Inter', size: 11, weight: '600' }
                                }
                            }
                        }
                    }
                });
            }
        }
    </script>

    <script>
        // --- START: SCRIPT from index2.html ---

        // Data for the top 27 companies (as provided in the prompt)
        const tier1Data = [
            { rank: 1, company: 'AstronauTx', city: 'London (White City)', country: 'UK', focus: 'AAV Gene Therapy', raised: 130, employees: 80, tier: 1, color: '#EF4444', modality: 'AAV' },
            { rank: 2, company: 'Quell Therapeutics', city: 'London', country: 'UK', focus: 'Regulatory CAR-T', raised: 200, employees: 120, tier: 1, color: '#EF4444', modality: 'Cell Therapy' },
            { rank: 3, company: 'Freeline Therapeutics', city: 'Stevenage', country: 'UK', focus: 'AAV Capsids', raised: 250, employees: 100, tier: 1, color: '#EF4444', modality: 'AAV' },
            { rank: 4, company: 'Autolus Therapeutics', city: 'London (White City)', country: 'UK', focus: 'CAR-T', raised: 400, employees: 450, tier: 1, color: '#EF4444', modality: 'Cell Therapy' },
            { rank: 5, company: 'Achilles Therapeutics', city: 'London', country: 'UK', focus: 'Personalized Cancer Vaccines', raised: 200, employees: 140, tier: 1, color: '#EF4444', modality: 'Cell Therapy' },
            { rank: 6, company: 'CellCentric', city: 'Cambridge', country: 'UK', focus: 'p300/CBP inhibitor + cell', raised: 75, employees: 70, tier: 1, color: '#EF4444', modality: 'Small Mol + Cell' },
            { rank: 7, company: 'Bit Bio', city: 'Cambridge', country: 'UK', focus: 'iPSC-derived cells', raised: 200, employees: 220, tier: 1, color: '#EF4444', modality: 'Cell Therapy' },
            { rank: 8, company: 'Exscientia', city: 'Oxford', country: 'UK', focus: 'AI + Biologics', raised: 700, employees: 400, tier: 1, color: '#EF4444', modality: 'AI/Biologics' },
            { rank: 9, company: 'BenevolentAI', city: 'London', country: 'UK', focus: 'AI + Cell Screening', raised: 350, employees: 200, tier: 1, color: '#EF4444', modality: 'AI/Cell' },
            { rank: 10, company: 'Isomorphic Labs', city: 'London', country: 'UK', focus: 'Massive Lab Buildout', raised: 500, employees: 150, tier: 1, color: '#EF4444', modality: 'AI/Struct. Bio' },
            { rank: 11, company: 'BioNTech (UK Sites)', city: 'Cambridge', country: 'UK', focus: 'mRNA, CAR-T, iPSC', raised: 1000, employees: 500, tier: 1, color: '#EF4444', modality: 'mRNA/Cell Therapy', public: true },
            { rank: 12, company: 'CureVac', city: 'T√ºbingen', country: 'Germany', focus: 'mRNA Vaccines/Therapy', raised: 1200, employees: 1000, tier: 1, color: '#EF4444', modality: 'mRNA', public: true },
            { rank: 13, company: 'Evotec (New Sites)', city: 'Hamburg, G√∂ttingen', country: 'Germany', focus: 'iPSC, AAV, CAR-T CDMO', raised: 2000, employees: 5000, tier: 1, color: '#EF4444', modality: 'CDMO/Cell & Gene', public: true },
            { rank: 14, company: 'CatalYm', city: 'Munich', country: 'Germany', focus: 'GDF-15 Antibody + Cell Combo', raised: 150, employees: 80, tier: 1, color: '#EF4444', modality: 'Antibody/Cell' },
            { rank: 15, company: 'Immatics', city: 'T√ºbingen', country: 'Germany', focus: 'TCR Engineering', raised: 450, employees: 400, tier: 1, color: '#EF4444', modality: 'TCR-T' },
            { rank: 16, company: 'Tubulis', city: 'Munich', country: 'Germany', focus: 'P5 Conjugation ADC', raised: 200, employees: 100, tier: 1, color: '#EF4444', modality: 'ADC' },
            { rank: 17, company: 'ITM Isotope Technologies', city: 'Munich', country: 'Germany', focus: 'Radioconjugates', raised: 300, employees: 400, tier: 1, color: '#EF4444', modality: 'Radiopharma' },
            { rank: 18, company: 'Ariceum Therapeutics', city: 'Berlin', country: 'Germany', focus: 'Radiopharma', raised: 100, employees: 60, tier: 1, color: '#EF4444', modality: 'Radiopharma' },
            { rank: 19, company: 'Lysogene (Sarepta-owned)', city: 'Paris', country: 'France', focus: 'AAV CNS Gene Therapy', raised: 50, employees: 50, tier: 1, color: '#EF4444', modality: 'AAV' },
            { rank: 20, company: 'Sensorion', city: 'Montpellier', country: 'France', focus: 'AAV Inner Ear Gene Therapy', raised: 100, employees: 60, tier: 1, color: '#EF4444', modality: 'AAV' },
            { rank: 21, company: 'Genethon', city: 'Evry', country: 'France', focus: 'AAV, Lentiviral Nonprofit', raised: 250, employees: 300, tier: 1, color: '#EF4444', modality: 'AAV/Lentiviral' },
            { rank: 22, company: 'Novo Nordisk (Cell Expansion)', city: 'Copenhagen', country: 'Denmark', focus: 'Stem Cell Therapy', raised: 5000, employees: 500, tier: 1, color: '#EF4444', modality: 'Stem Cell' },
            { rank: 23, company: 'Minervax', city: 'Copenhagen', country: 'Denmark', focus: 'GBS Vaccine', raised: 100, employees: 50, tier: 1, color: '#EF4444', modality: 'Vaccine/Cell' },
            { rank: 24, company: 'Adcendo', city: 'Copenhagen', country: 'Denmark', focus: 'ADC', raised: 150, employees: 70, tier: 1, color: '#EF4444', modality: 'ADC' },
            { rank: 25, company: 'NMD Pharma', city: 'Aarhus', country: 'Denmark', focus: 'Ion Channel Assays', raised: 100, employees: 60, tier: 1, color: '#EF4444', modality: 'Small Mol/Cell' },
            { rank: 26, company: 'Lonza (Viral Vector)', city: 'Basel, Stein', country: 'Switzerland', focus: 'AAV, Lentiviral CDMO', raised: 8000, employees: 10000, tier: 1, color: '#EF4444', modality: 'CDMO/Gene Therapy', public: true },
            { rank: 27, company: 'CRISPR Therapeutics', city: 'Zug', country: 'Switzerland', focus: 'CRISPR Cas9', raised: 750, employees: 500, tier: 1, color: '#EF4444', modality: 'CRISPR/Cell' }
            // Ranks 28-42 are summarized as 'Similar high-fit names...'
        ];

        // --- Utility Functions ---

        function getModalityBadge(modality) {
            let className = '';
            if (modality.includes('AAV') || modality.includes('Gene Therapy') || modality.includes('Lentiviral')) {
                className = 'badge-color-aav';
            } else if (modality.includes('Cell Therapy') || modality.includes('CAR-T') || modality.includes('iPSC') || modality.includes('Stem Cell')) {
                className = 'badge-color-cell';
            } else if (modality.includes('mRNA')) {
                className = 'badge-color-mrna';
            } else if (modality.includes('ADC') || modality.includes('Radiopharma')) {
                className = 'badge-color-adc';
            } else {
                className = 'bg-gray-400 text-white';
            }
            return `<span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium ${className}">${modality.split('/')[0].trim()}</span>`;
        }
        
        // --- Table Initialization ---

        function populateTable() {
            const tbody = document.getElementById('tier1TableBody');
            if (!tbody) return;
            tbody.innerHTML = ''; // Clear existing rows

            // Filter data to show the top 20 (or max available)
            const displayData = tier1Data.slice(0, 20);

            displayData.forEach(company => {
                const row = document.createElement('tr');
                row.classList.add('hover:bg-gray-50');

                row.innerHTML = `
                    <td class="px-3 py-4 whitespace-nowrap text-sm font-medium text-gray-900">${company.rank}</td>
                    <td class="px-6 py-4 whitespace-nowrap text-sm font-medium text-indigo-600">${company.company}</td>
                    <td class="px-6 py-4 whitespace-nowrap text-sm text-gray-500">
                        <span class="font-semibold">${company.country}</span>, ${company.city}
                    </td>
                    <td class="px-6 py-4 whitespace-nowrap">
                        ${getModalityBadge(company.focus)}
                    </td>
                    <td class="px-6 py-4 whitespace-nowrap text-sm text-gray-900 font-semibold">$${company.raised.toLocaleString()}M${company.public ? ' (Public)' : '+'}</td>
                    <td class="px-6 py-4 whitespace-nowrap text-sm text-gray-500">${company.employees.toLocaleString()}${company.public ? '+' : ''}</td>
                `;
                tbody.appendChild(row);
            });
        }

        // --- Chart Initialization ---

        function initProspectingCharts() {
            const ctx = document.getElementById('prioritizationChart');
            if (!ctx) return;

            // Convert data for the bubble chart
            const chartData = tier1Data.map(c => {
                // Adjust size (r) based on combined funding and employees, and cap large outliers like Lonza/Novo Nordisk
                let sizeFactor = 1;
                if (c.public) {
                    // Public/Massive companies get a larger fixed size to represent scale
                    sizeFactor = 1.8;
                } else if (c.raised > 300) {
                    sizeFactor = 1.4;
                }
                const r = Math.min(20, (Math.log10(c.raised * c.employees) * sizeFactor)); 
                
                // Map raised values (in millions) to Y-axis. Cap for visualization clarity.
                const yValue = Math.min(c.raised, 800); 

                // Map employees to X-axis. Cap for visualization clarity.
                const xValue = Math.min(c.employees, 550); 

                return {
                    x: xValue, // Employees (X)
                    y: yValue, // Raised (Y)
                    r: r,      // Size (Combined scale)
                    company: c.company,
                    country: c.country,
                    focus: c.focus
                };
            });

            new Chart(ctx.getContext('2d'), {
                type: 'bubble',
                data: {
                    datasets: [{
                        label: 'Tier 1 Targets',
                        data: chartData,
                        backgroundColor: chartData.map(d => 'rgba(239, 68, 68, 0.7)'), // Red 500
                        borderColor: chartData.map(d => '#EF4444'),
                        hoverBackgroundColor: 'rgba(185, 28, 28, 0.9)', // Red 700
                        hoverBorderColor: '#B91C1C',
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    plugins: {
                        legend: { display: false },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    const data = context.raw;
                                    return [
                                        `Company: ${data.company}`,
                                        `Country: ${data.country}`,
                                        `Focus: ${data.focus}`,
                                        `Raised: $${data.y.toLocaleString()}M+`,
                                        `Employees: ${data.x.toLocaleString()}+`,
                                    ];
                                }
                            }
                        },
                        title: {
                            display: true,
                            text: 'Investment vs. Scale for Tier 1 Prospects',
                            font: { size: 16, weight: 'bold' },
                            color: '#1f2937'
                        }
                    },
                    scales: {
                        x: {
                            type: 'linear',
                            position: 'bottom',
                            title: {
                                display: true,
                                text: 'Employee Headcount (Scaled)',
                                color: '#4b5563',
                                font: { weight: 'bold' }
                            },
                            ticks: {
                                callback: (value) => `${value}+`,
                                stepSize: 100
                            },
                            grid: { color: '#e5e7eb' },
                            min: 0,
                            max: 600
                        },
                        y: {
                            title: {
                                display: true,
                                text: 'Total Capital Raised (M USD - Scaled)',
                                color: '#4b5563',
                                font: { weight: 'bold' }
                            },
                            ticks: {
                                callback: (value) => `$${value}M+`,
                                stepSize: 100
                            },
                            grid: { color: '#e5e7eb' },
                            min: 0,
                            max: 850
                        }
                    }
                }
            });
        }

        // --- App Load Logic ---

        function initializeAllContent() {
            // From original index.html
            initMainCharts();

            // From original index2.html
            populateTable();
            initProspectingCharts();

            // Universal
            lucide.createIcons();
        }

        if (typeof Chart !== 'undefined') {
            if (document.readyState === 'loading') {
                document.addEventListener('DOMContentLoaded', initializeAllContent);
            } else {
                initializeAllContent();
            }
        } else {
            window.addEventListener('load', initializeAllContent);
        }
        
    </script>
</body>
</html>